Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene

Clusterin (CLU), a heterodimeric and sulfated glycoprotein has been associated with various physiological functions. This molecular chaperone protein is ubiquitously expressed in diverse tissues and conserved across species. Differences in subcellular localization and possible existence of different...

Full description

Bibliographic Details
Main Authors: Rajashree Kadam, Tanuja Teni
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Biomedical Research Journal
Subjects:
Online Access:http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=2;spage=130;epage=156;aulast=Kadam;type=0
_version_ 1818434951342718976
author Rajashree Kadam
Tanuja Teni
author_facet Rajashree Kadam
Tanuja Teni
author_sort Rajashree Kadam
collection DOAJ
description Clusterin (CLU), a heterodimeric and sulfated glycoprotein has been associated with various physiological functions. This molecular chaperone protein is ubiquitously expressed in diverse tissues and conserved across species. Differences in subcellular localization and possible existence of different CLU isoforms may contribute to its functional diversity. Increased or decreased expression of CLU has been observed in several cancers versus normal tissues and hence its role in tumorigenesis is controversial. Evidences from several studies imply that CLU may have a dual role as a tumor suppressor gene or an oncogene depending on the signal and cellular context. CLU possibly exerts its oncogenic role by inhibiting apoptosis, activating autophagy and modulating several signaling pathways like IGF-1/IGFR, EGFR, NF-kB, PI3K/AKT, TGFp and select miRNAs. CLU may exert its tumor suppressive effects by regulating cell cycle and inducing apoptosis. In cancer, loss of heterozygosity (LOH), copy number loss at CLU locus, epigenetic modifications and expression of select miRNAs may lead to the downregulation of CLU. Custirsen (OGX-011), a second generation antisense oligonucleotide that inhibits CLU expression and increases sensitivity of cancer cells to chemotherapeutic drugs, is currently in phase III clinical trials. CLU is an attractive target in several cancers, however for effective targeting, it is essential to know whether it acts as an oncogene or a tumor suppressor gene in a specific tissue/cellular context. The current review attempts to discuss the two contrasting roles of CLU in cancer and associated regulatory mechanisms. This review also sheds light on the complex CLU splice variants, the varied functional attributes supporting the dual roles in cancer and limitations of the CLU research that warrant attention.
first_indexed 2024-12-14T16:45:09Z
format Article
id doaj.art-b9941ba20fc34e46a2be5f2c59c07025
institution Directory Open Access Journal
issn 2349-3666
2349-3674
language English
last_indexed 2024-12-14T16:45:09Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Biomedical Research Journal
spelling doaj.art-b9941ba20fc34e46a2be5f2c59c070252022-12-21T22:54:12ZengWolters Kluwer Medknow PublicationsBiomedical Research Journal2349-36662349-36742016-01-013213015610.4103/2349-3666.240609Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogeneRajashree KadamTanuja TeniClusterin (CLU), a heterodimeric and sulfated glycoprotein has been associated with various physiological functions. This molecular chaperone protein is ubiquitously expressed in diverse tissues and conserved across species. Differences in subcellular localization and possible existence of different CLU isoforms may contribute to its functional diversity. Increased or decreased expression of CLU has been observed in several cancers versus normal tissues and hence its role in tumorigenesis is controversial. Evidences from several studies imply that CLU may have a dual role as a tumor suppressor gene or an oncogene depending on the signal and cellular context. CLU possibly exerts its oncogenic role by inhibiting apoptosis, activating autophagy and modulating several signaling pathways like IGF-1/IGFR, EGFR, NF-kB, PI3K/AKT, TGFp and select miRNAs. CLU may exert its tumor suppressive effects by regulating cell cycle and inducing apoptosis. In cancer, loss of heterozygosity (LOH), copy number loss at CLU locus, epigenetic modifications and expression of select miRNAs may lead to the downregulation of CLU. Custirsen (OGX-011), a second generation antisense oligonucleotide that inhibits CLU expression and increases sensitivity of cancer cells to chemotherapeutic drugs, is currently in phase III clinical trials. CLU is an attractive target in several cancers, however for effective targeting, it is essential to know whether it acts as an oncogene or a tumor suppressor gene in a specific tissue/cellular context. The current review attempts to discuss the two contrasting roles of CLU in cancer and associated regulatory mechanisms. This review also sheds light on the complex CLU splice variants, the varied functional attributes supporting the dual roles in cancer and limitations of the CLU research that warrant attention.http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=2;spage=130;epage=156;aulast=Kadam;type=0clusterincancertumor suppressor geneoncogenechaperonestress
spellingShingle Rajashree Kadam
Tanuja Teni
Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
Biomedical Research Journal
clusterin
cancer
tumor suppressor gene
oncogene
chaperone
stress
title Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
title_full Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
title_fullStr Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
title_full_unstemmed Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
title_short Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
title_sort clusterin in cancer dual role as a tumor suppressor gene and an oncogene
topic clusterin
cancer
tumor suppressor gene
oncogene
chaperone
stress
url http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=2;spage=130;epage=156;aulast=Kadam;type=0
work_keys_str_mv AT rajashreekadam clusterinincancerdualroleasatumorsuppressorgeneandanoncogene
AT tanujateni clusterinincancerdualroleasatumorsuppressorgeneandanoncogene